THE DEFINITIVE ARTICLE SEARCH FOR THE GLOBAL PHARMACEUTICALS MARKET Advanced Search
 
Pharma space image
ARCHI-TECH UNVEILS LATEST VERSION OF PHARMACEUTICAL ANALYTICS & REPORTING SOLUTION
Pharma
Archi-Tech Systems
01/06/2007
 
New Functionality Added in Direct Response to Customer Needs, Including Increased Automation, Expanded Export Capabilities, and More

Archi-Tech Systems, a leader in pharmaceutical data analysis and reporting solutions, today announced the latest release of DART(TM) (Data Analysis & Reporting Tool), the company's flagship solution for instant, in-depth analytics and reporting on pharmaceutical sales, marketing, and managed care data. The new version has been expanded to meet specific customer requests, including increased automation for reporting, expanded options for exporting data, and more.

"Like all of Archi-Tech's solutions, DART is designed to integrate pharmaceutical data with a company's individual needs, business rules, internal data, and metrics - offering deeper, more intuitive access to drive fast decision support, sales planning, and performance tracking," said Prashant Kohli, Vice President of Sales and Marketing for Archi-Tech. "Part of this approach means that we also listen closely to our customers' needs, and continuously expand our solutions to deliver new features and functionality to save time and simplify reporting and analysis."

DART offers a fully interactive query environment to run ad-hoc searches, platform data, create graphical reports, and export critical data within seconds, offering unlimited searching, reporting, and graphing capabilities for any configuration of data, across any parameter. DART integrates, compresses, and indexes large volumes of complex data from multiple sources into a single view, including syndicated data from vendors like IMS, WK, Verispan, or specialty pharmacy data providers, input from SFA systems like Dendrite, Siebel, or in-house applications, and in-house prescriber demographics, market definitions, sales force and plan alignments, and more. In addition, because DART requires no Internet connection, its full functionality is always available offline - anywhere, anytime, whether at the home office or in the field.

DART offers a complete suite of products that is continuously expanded to meet emerging data trends and client needs, and can be customized to support any type of data on the market - including Weekly, Prescriber, Managed Markets, Outlet, LRx, and more. For more information, contact Archi-Tech at 609-882-2447 or sales@archi-tech.com.

About Archi-Tech

Archi-Tech Systems is a leading provider of solutions for instant analytics and powerful reporting for pharmaceutical sales, marketing, and managed care departments. Balancing deep data expertise with advanced technology solutions and a unique service model, Archi-Tech addresses the full scope of a company's data analysis and reporting needs, no matter how simple or complex. Archi-Tech's InPress(R) engine is the industry's most powerful indexing and compression technology - delivering unmatched query response times for any type of data, from any source, regardless of volume or complexity. In addition, the Archi-Tech team offers more than 100 years of combined experience with industry leading data vendors, and direct pharmaceutical client service experience. This translates to a unique understanding of the data, and exactly how our clients need to use it. For more information, visit www.archi-tech.com.

Media Contact: Lin Lawson Resound Marketing 609-279-0050 x103 lin@resoundmarketing.com SOURCE Archi-Tech Systems
Pharma
 
View similar articles:  
Pharma
   
CommunityArticles People who viewed this article were also interested inCommunityArticles   CommunityArticles
SupplierArticles Other articles from Archi-Tech SystemsSupplierArticles   SupplierArticles
Miscategorized Article Miscategorized Article Miscategorized Article
 
Click hereto report a mis-classified article
space image
Miscategorized Article Miscategorized Article Miscategorized Article
Article Report Abuse Article Report Abuse Article Report Abuse
 
Click hereto report an abusive or defamatory article
Report Article Abuse
Report Article Abuse Report Article Abuse Report Article Abuse
 
© CMP information Ltd 2007
Terms and Conditions  Privacy Policy